Skip to main content

Advertisement

SpringerLink
Log in

The expression of miRNA-221 and miRNA-222 in gliomas patients and their prognosis

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

The aim of this study is to explore the expression of microRNA (miRNA)-221 and miRNA-222 in human glioma cells and tissues. The expression of miRNA-221 and miRNA-222 in human glioma cell line U87, U251, A172, LN229 and surgery resected glioma tissues were measured. The survival rate of X-ray (2 Gy) irradiated glioma cells were calculated. 165 cases of glioma patients were recruited successfully; the expression of miRNA-221 and miRNA-222 in their resected tissues were measured. The expression of miRNA-221 and miRNA-222 in cancer tissues were obviously higher than control tissues (normal brain tissue) and control cell (gastric mucosal epithelial cell, GES) (p < 0.05). The highly malignant glioma tissues expressed significantly higher miRNA-221 and miRNA-222 than low malignant glioma tissues. Patients with highly expressed miRNA-221 and miRNA-222 have shorter survival time. Survival rate of glioma cells was significantly higher than GES cell after irradiation (p < 0.05); miRNA-221 in glioma cells. The expressions of miRNA-221 and miRNA-222 in irritated glioma cells were positively correlated with the survival rate of glioma cells (r = 0.629, 0.712, both p < 0.01). For the 165 glioma patients, the expressions of miRNA-221 and miRNA-222 increased with the increasing of pathological grades (χ 2 = 42.85, p < 0.01); and their survival time decreased when miRNA-221 expression elevated (χ 2 = 57.12, p < 0.01). MiRNA-221 and miRNA-222 express highly in human glioma cells and tissues. Expression of miRNA-221 and miRNA-222 are closely related to pathological grading and prognosis of glioma; they could be used as independent prognostic factor for glioma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Wong ET, Lok E, Swanson KD (2015) An evidence-based review of alternating electric fields therapy for malignant gliomas. Curr Treat Options Oncol 16(8):40. doi:10.1007/s11864-015-0353-5

    Article  PubMed  PubMed Central  Google Scholar 

  2. Yoo RE, Choi SH (2015) Recent application of advanced MR imaging to predict pseudoprogression in high-grade glioma patients. Magn Reson Med Sci MRMS Off J Jpn Soc Magn Reson Med. doi:10.2463/mrms.rev.2015-0053

    Google Scholar 

  3. Hamza MA, Mandel JJ, Conrad CA, Gilbert MR, Yung WK, Puduvalli VK, DeGroot JF (2014) Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma. J Neurooncol 119(1):135–140. doi:10.1007/s11060-014-1460-z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ghiaseddin A, Peters KB (2015) Use of bevacizumab in recurrent glioblastoma. CNS oncology 4(3):157–169. doi:10.2217/cns.15.8

    Article  CAS  PubMed  Google Scholar 

  5. Glass R, Synowitz M (2014) CNS macrophages and peripheral myeloid cells in brain tumours. Acta Neuropathol 128(3):347–362. doi:10.1007/s00401-014-1274-2

    Article  CAS  PubMed  Google Scholar 

  6. Hamza MA, Kamiya-Matsuoka C, Liu D, Yuan Y, Puduvalli VK (2016) Outcome of patients with malignant glioma and synchronous or metachronous non-central nervous system primary neoplasms. J Neurooncol 126(3):527–533. doi:10.1007/s11060-015-1992-x

    Article  PubMed  Google Scholar 

  7. Zeng T, Cui D, Gao L (2015) Glioma: an overview of current classifications, characteristics, molecular biology and target therapies. Front Biosci 20:1104–1115

    Article  Google Scholar 

  8. Villa S, Balana C, Comas S (2014) Radiation and concomitant chemotherapy for patients with glioblastoma multiforme. Chin J Cancer 33(1):25–31. doi:10.5732/cjc.013.10216

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Yang LJ, Zhou CF, Lin ZX (2014) Temozolomide and radiotherapy for newly diagnosed glioblastoma multiforme: a systematic review. Cancer Invest 32(2):31–36. doi:10.3109/07357907.2013.861474

    Article  PubMed  Google Scholar 

  10. Paulsson J, Lindh MB, Jarvius M, Puputti M, Nister M, Nupponen NN, Paulus W, Soderberg O, Dresemann G, von Deimling A, Joensuu H, Ostman A, Hasselblatt M (2011) Prognostic but not predictive role of platelet-derived growth factor receptors in patients with recurrent glioblastoma. Int J Cancer 128(8):1981–1988. doi:10.1002/ijc.25528

    Article  CAS  PubMed  Google Scholar 

  11. Bambury RM, Teo MY, Power DG, Yusuf A, Murray S, Battley JE, Drake C, O’Dea P, Bermingham N, Keohane C, Grossman SA, Moylan EJ, O’Reilly S (2013) The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme. J Neurooncol 114(1):149–154. doi:10.1007/s11060-013-1164-9

    Article  CAS  PubMed  Google Scholar 

  12. Kogiku M, Ohsawa I, Matsumoto K, Sugisaki Y, Takahashi H, Teramoto A, Ohta S (2008) Prognosis of glioma patients by combined immunostaining for survivin, Ki-67 and epidermal growth factor receptor. J Clin Neurosci Off J Neurosurg Soc Australas 15(11):1198–1203. doi:10.1016/j.jocn.2007.11.012

    CAS  Google Scholar 

  13. Tian X, Zhang L, Sun L, Xue Y, Xie S (2014) Low expression of insulin-like growth factor binding protein 7 associated with poor prognosis in human glioma. J Int Med Res 42(3):651–658. doi:10.1177/0300060513503926

    Article  PubMed  Google Scholar 

  14. Kuang XY, Jiang XF, Chen C, Su XR, Shi Y, Wu JR, Zhang P, Zhang XL, Cui YH, Ping YF, Bian XW (2015) Expressions of glia maturation factor-beta by tumor cells and endothelia correlate with neovascularization and poor prognosis in human glioma. Oncotarget. doi:10.18632/oncotarget.5509

    Google Scholar 

  15. Yang X, Lv S, Zhou X, Liu Y, Li D, Shi R, Kang H, Zhang J, Xu Z (2015) The clinical implications of transforming growth factor beta in pathological grade and prognosis of glioma patients: a meta-analysis. Mol Neurobiol 52(1):270–276. doi:10.1007/s12035-014-8872-9

    Article  CAS  PubMed  Google Scholar 

  16. Qin B, Cao Y, Yang H, Xiao B, Lu Z (2015) MicroRNA-221/222 regulate ox-LDL-induced endothelial apoptosis via Ets-1/p21 inhibition. Mol Cell Biochem 405(1–2):115–124. doi:10.1007/s11010-015-2403-5

    Article  CAS  PubMed  Google Scholar 

  17. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM, Farace MG (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334(4):1351–1358. doi:10.1016/j.bbrc.2005.07.030

    Article  CAS  PubMed  Google Scholar 

  18. Zhang CZ, Kang CS, Pu PY, Wang GX, Jia ZF, Zhang AL, Han L, Xu P (2009) Inhibitory effect of knocking down microRNA-221 and microRNA-222 on glioma cell growth in vitro and in vivo. Zhonghua zhong liu za zhi [Chin J Oncol] 31(10):721–726

    CAS  Google Scholar 

  19. Nowak AK, Maujean JE, Jackson M, Knuckey N (2011) A prospective study of surgical patterns of care for high grade glioma in the current era of multimodality therapy. J Clin Neurosci Off J Neurosurg Soc Australas 18(2):227–231. doi:10.1016/j.jocn.2010.05.009

    CAS  Google Scholar 

  20. Atkins RJ, Ng W, Stylli SS, Hovens CM, Kaye AH (2015) Repair mechanisms help glioblastoma resist treatment. J Clin Neurosci Off J Neurosurg Soc Australas 22(1):14–20. doi:10.1016/j.jocn.2014.09.003

    Google Scholar 

  21. Wu L, Li G, Feng D, Qin H, Gong L, Zhang J, Zhang Z (2013) MicroRNA-21 expression is associated with overall survival in patients with glioma. Diagn Pathol 8:200. doi:10.1186/1746-1596-8-200

    Article  PubMed  PubMed Central  Google Scholar 

  22. Sun L, Yan W, Wang Y, Sun G, Luo H, Zhang J, Wang X, You Y, Yang Z, Liu N (2011) MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res 1389:9–18. doi:10.1016/j.brainres.2011.03.013

    Article  CAS  PubMed  Google Scholar 

  23. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21(21):2683–2710. doi:10.1101/gad.1596707

    Article  CAS  PubMed  Google Scholar 

  24. Hu H, Du L, Nagabayashi G, Seeger RC, Gatti RA (2010) ATM is down-regulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci USA 107(4):1506–1511. doi:10.1073/pnas.0907763107

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Oh JS, Kim JJ, Byun JY, Kim IA (2010) Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras. Int J Radiat Oncol Biol Phys 76(1):5–8. doi:10.1016/j.ijrobp.2009.08.028

    Article  CAS  PubMed  Google Scholar 

  26. Zhang CZ KC, Pu PY, Wang GX, Jia ZF, Zhang AL, Han L, Xu P (2009) Inhibitory effect of knocking down microRNA221 and microRNA222 on glioma cell growth in vitro and in vivo. Chin J Oncol 31(10)

  27. Wang S, Zhang R, Claret FX, Yang H (2014) Involvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiation. Mol Cancer Ther 13(12):3163–3174. doi:10.1158/1535-7163.MCT-14-0317

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Bae S, Kim K, Cha HJ, Choi Y, Shin SH, An IS, Lee JH, Song JY, Yang KH, Nam SY, An S (2014) Altered microRNA expression profiles are involved in resistance to low-dose ionizing radiation in the absence of BMI1 in human dermal fibroblasts. Int J Oncol 45(4):1618–1628. doi:10.3892/ijo.2014.2542

    CAS  PubMed  Google Scholar 

  29. Bourguignon LY, Shiina M, Li JJ (2014) Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression. Adv Cancer Res 123:255–275. doi:10.1016/B978-0-12-800092-2.00010-1

    Article  CAS  PubMed  Google Scholar 

  30. Wang G, Wang JJ, Tang HM, To SS (2015) Targeting strategies on miRNA-21 and PDCD4 for glioblastoma. Arch Biochem Biophys 580:64–74. doi:10.1016/j.abb.2015.07.001

    Article  CAS  PubMed  Google Scholar 

  31. Li Y, Zhao S, Zhen Y, Li Q, Teng L, Asai A, Kawamoto K (2011) A miR-21 inhibitor enhances apoptosis and reduces G(2)-M accumulation induced by ionizing radiation in human glioblastoma U251 cells. Brain tumor pathology 28(3):209–214. doi:10.1007/s10014-011-0037-1

    Article  PubMed  Google Scholar 

  32. Gwak HS, Kim TH, Jo GH, Kim YJ, Kwak HJ, Kim JH, Yin J, Yoo H, Lee SH, Park JB (2012) Silencing of microRNA-21 confers radiosensitivity through inhibition of the PI3 K/AKT pathway and enhancing autophagy in malignant glioma cell lines. PLoS One 7(10):e47449. doi:10.1371/journal.pone.0047449

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Asuthkar S, Velpula KK, Chetty C, Gorantla B, Rao JS (2012) Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity. Oncotarget 3(11):1439–1454. doi:10.18632/oncotarget.683

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Tianjin Medical University General Hospital, 54 Anshan Road, Heping District, Tianjin, 300052, People’s Republic of China

    Liang Xue, Yi Wang, Shuyuan Yue & Jianning Zhang

Authors
  1. Liang Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shuyuan Yue
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jianning Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Liang Xue.

Ethics declarations

Conflict of interest

The authors declare there is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xue, L., Wang, Y., Yue, S. et al. The expression of miRNA-221 and miRNA-222 in gliomas patients and their prognosis. Neurol Sci 38, 67–73 (2017). https://doi.org/10.1007/s10072-016-2710-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-016-2710-y

Keywords

Search

Navigation